AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Brolucizumab in Nigeria
1 product registered with NAFDAC — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Pagenax 120 mg/mL Solution for Injection** Solution for intravitreal injection | A6-100100 | Novartis Nigeria Limited | active | 29 Mar 2028 |
Brolucizumab — NAFDAC Registration Details
NAFDAC (Nigeria) has 1 registered product containing Brolucizumab, of which 1 is currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Brolucizumab registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.